HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Business (Cosmetics)

Deals

Set Alert for Deals (Beauty)

Latest From Beauty & Deals

Beiersdorf Partners With Biopharma For Anti-Aging Skin Care Innovation; Beauty Business News

With NIVEA driving growth in its Consumer division, German firm Beiersdorf AG has signed a multi-year deal with Rubedo Life Sciences to develop anti-aging solutions and new products for the global market. More beauty business news, including L’Oreal, Inter Parfums, Galderma, and LVMH/Sephora sales updates.

Business Strategies Sales & Earnings

China Drags On Shiseido, Kao In 2023; Sally Beauty Partners With Black Hair Experience; Beauty News

Shiseido and Kao report China and travel retail were significant headwinds in 2023, though both expect smoother sailing ahead. More beauty news in brief.

Sales & Earnings Deals

Natura Considers Avon Separation; LVMH Highlights Sephora Growth In 2023; Beauty News In Brief

Splitting off Avon as its own publicly traded company would unlock shareholder value and provide shareholders with greater visibility into the entities’ performance and potential, Natura says. Sephora sales fueled 20% reported growth in LVMH’s Selective Retailing business in 2023. More beauty news.

Deals Leadership
See All

Strategy

Set Alert for Strategy (Beauty)

Latest From Beauty & Business Strategies

Over The Counter: Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta

In this episode of the updated Over The Counter podcast, HBW Insight speaks to sustainable packaging expert Tony Perrotta about the complexities of replacing plastic pill packs in medicines packaging. Perrotta is a partner at PA Consulting, which set up the Blister Pack Collective alongside consumer health players Haleon, Bayer and Sanofi. They are working with PulPac, which has invented a dry molded fiber alternative to plastic, which the Collective hopes to commercialize within 12-24 months. We discuss whether regulators will accept such alternatives, given the safety and stability requirements for medicines, and the challenges of recycling, given the multitude of different frameworks and processes across the world. Perrotta also reveals that one of the partners in PA Consulting’s Bottle Collective, which hopes to replace plastic bottles in the food, personal care and consumer health industries, will soon launch its first market trial.

International Health

Coty’s Social Media Investments Have CoverGirl, Rimmel On More Lips, Minds And Receipts

On the wings of innovation and a new host of influencers, Coty says CoverGirl ranked number three in the US in earned media value among its peer set in the third quarter ended 31 March, versus sixth in the same period last year. CEO Sue Nabi had more to say about the firm’s social media “step-changing” in her remarks on Q3 results.

Companies Sales & Earnings

Kenvue Cutting Staff 4% After Year Apart From J&J

Along with latest results, Kenvue says as its “transitions services agreement” with J&J ends, its board approves reducing global workforce by around 4%. It expects around $275m in pre-tax restructuring costs in both 2024 and 2025 without changes to its capital allocation priorities.

Sales & Earnings Consumer
See All

Sales & Earnings

Set Alert for Sales & Earnings (Beauty)

Latest From Beauty & Sales & Earnings

Coty’s Social Media Investments Have CoverGirl, Rimmel On More Lips, Minds And Receipts

On the wings of innovation and a new host of influencers, Coty says CoverGirl ranked number three in the US in earned media value among its peer set in the third quarter ended 31 March, versus sixth in the same period last year. CEO Sue Nabi had more to say about the firm’s social media “step-changing” in her remarks on Q3 results.

Companies Sales & Earnings

Kenvue Cutting Staff 4% After Year Apart From J&J

Along with latest results, Kenvue says as its “transitions services agreement” with J&J ends, its board approves reducing global workforce by around 4%. It expects around $275m in pre-tax restructuring costs in both 2024 and 2025 without changes to its capital allocation priorities.

Sales & Earnings Consumer

Bausch + Lomb’s Prescription For Consumer Health Sales Growth Includes ‘Benefit’ From Rx Drugs

Blink NutriTears supplement containing lutein/zeaxanthin, curcumin and vitamin D3 coming in 2024 is example of a cross-segment sales benefit B+L sees in dry eye product category. Consumer eye care and vision health product sales are key drivers for 18% Q1 net sales growth to $1.1bn.

Consumer Sales & Earnings
See All
UsernamePublicRestriction

Register